Plasmakoncentrationen af celecoxib kan reduceres ved samtidig brug af CYP2C9- induktorer som rifampicin, carbamazepin og barbiturater.
Concomitant use of inducers of CYP2C9 such as rifampicin, carbamazepine and barbiturates may reduce plasma concentrations of celecoxib.